Targeting Aurora kinase activity in lung cancer cell driven by oncogenic KRAS impairs lung cancer initiating cell function (2015)
- Autores:
- Autor USP: BASSÈRES, DANIELA SANCHEZ - IQ
- Unidade: IQ
- Assuntos: ONCOGENES; NEOPLASIAS DO TRATO RESPIRATÓRIO
- Idioma: Inglês
- Imprenta:
- Editora: Sociedade Brasileira de Bioquímica e Biologia Molecular (SBBq)
- Local: São Paulo
- Data de publicação: 2015
- Fonte:
- Título do periódico: Abstracts Book
- Nome do evento: Congress of the International Union for Biochemistry and Molecular Biology - IUBMB
-
ABNT
SCALABRINI, Luiza Coimbra e CARNEIRO LOBO, Tatiana Correa e BASSÈRES, Daniela Sanchez. Targeting Aurora kinase activity in lung cancer cell driven by oncogenic KRAS impairs lung cancer initiating cell function. 2015, Anais.. São Paulo: Sociedade Brasileira de Bioquímica e Biologia Molecular (SBBq), 2015. . Acesso em: 29 mar. 2024. -
APA
Scalabrini, L. C., Carneiro Lobo, T. C., & Bassères, D. S. (2015). Targeting Aurora kinase activity in lung cancer cell driven by oncogenic KRAS impairs lung cancer initiating cell function. In Abstracts Book. São Paulo: Sociedade Brasileira de Bioquímica e Biologia Molecular (SBBq). -
NLM
Scalabrini LC, Carneiro Lobo TC, Bassères DS. Targeting Aurora kinase activity in lung cancer cell driven by oncogenic KRAS impairs lung cancer initiating cell function. Abstracts Book. 2015 ;[citado 2024 mar. 29 ] -
Vancouver
Scalabrini LC, Carneiro Lobo TC, Bassères DS. Targeting Aurora kinase activity in lung cancer cell driven by oncogenic KRAS impairs lung cancer initiating cell function. Abstracts Book. 2015 ;[citado 2024 mar. 29 ] - Aurora kinases: potential therapeutic targets in K-Ras-induced lung cancer
- Targeted BMI1 inhibition impairs tumor growth in lung adenocarcinomas with low CEBP alpha expression
- FOXO1 inhibition by oncogenic KRAS as an important mechanism promoting lung oncogenesis
- Requirement of the NF-'capa' B subunit p65/RelA for 'capa'-Ras-induced lung tumorigenesis
- Resenha sem título próprio
- Exploring IKKβ as an anti-angiogenic therapeutic target in KRAS-induced lung cancer
- IKK is a therapeutic target in KRAS-induced lung cancer with disrupted p53 activity
- Exploring IKKβ kinase as a therapeutic target for KRAS-driven lung tumor initiating cells
- Exploring IKKβ as an anti-metastatic therapeutic target in KRAS-induced lung cancer
- Targeting Aurora A kinase activity in lung cancer initiating cells driven by oncogenic KRAS
Como citar
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas